CRBU Caribou Biosciences, Inc.: institutional ownership and insider trading

148 funds reported holding $93.1M of Caribou Biosciences, Inc. in their latest 13F filings; in Q2 2026 funds net bought $18.3M, with 23 new positions and 22 funds selling out; over the last 12 months insiders bought $0 and sold $47.5K on the open market; over its last four quarters it reported revenue of $10.0M and net income of −$103M.

CRBU revenue and earnings

Famous investors holding CRBU

Largest institutional holders of CRBU

  1. BlackRock, Inc. (BLK) — $13.8M
  2. PFIZER INC (PFE) — $7.88M
  3. VANGUARD CAPITAL MANAGEMENT LLC — $7.41M
  4. VANGUARD GROUP INC — $6.84M
  5. MACKENZIE FINANCIAL CORP — $6.43M
  6. RENAISSANCE TECHNOLOGIES LLC — $4.88M
  7. Kynam Capital Management, LP — $4.41M
  8. GEODE CAPITAL MANAGEMENT, LLC — $4.18M
  9. ACADIAN ASSET MANAGEMENT LLC — $3.12M
  10. STATE STREET CORP (STT, STT-PG) — $2.87M

Recent CRBU insider trades

5%+ owners

Who owns the most CRBU stock?

The largest institutional holders of Caribou Biosciences, Inc. in the latest 13F filings are BlackRock, Inc. (BLK) ($13.8M), PFIZER INC (PFE) ($7.88M), VANGUARD CAPITAL MANAGEMENT LLC ($7.41M).

Are insiders buying or selling CRBU?

Over the last 12 months insiders bought $0 and sold $47.5K of Caribou Biosciences, Inc. stock on the open market (SEC Form 4).

Which famous investors own CRBU?

Renaissance Technologies, Lee Ainslie, Two Sigma, Ken Griffin, Izzy Englander.

What was CRBU's revenue last quarter?

Caribou Biosciences, Inc. reported revenue of $1.50M for the quarter ended June 30, 2026, with net income of −$24.3M.

Which ETFs hold CRBU?

4 ETFs and mutual funds hold it among their top 100 positions, including BRUFX, NXTE, GNOM, QQQS.

All CRBU 13F holders · All CRBU insider trades